Cargando…

Myositis-Related Interstitial Lung Disease: A Respiratory Physician’s Point of View

Idiopathic inflammatory myositis (IIM) is an umbrella term for diseases of unknown origin that cause muscle inflammation. Dermatomyositis and polymyositis are IIMs that commonly cause interstitial lung disease (ILD). When a patient presents with ILD, the evaluation of whether the case displays the c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Waseda, Yuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230365/ https://www.ncbi.nlm.nih.gov/pubmed/34200737 http://dx.doi.org/10.3390/medicina57060599

Ejemplares similares

Management of Myositis-Associated Interstitial Lung Disease
por: Fujisawa, Tomoyuki
Publicado: (2021)

“Management of myositis associated interstitial lung disease”
por: Thong, Lorraine, et al.
Publicado: (2023)

High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease
por: Egashira, Ryoko
Publicado: (2021)

Analytic Morphomics in Myositis-Related Interstitial Lung Disease
por: O’Mahony, Alexander T., et al.
Publicado: (2023)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Prognostic Factors for Myositis-Associated Interstitial Lung Disease
por: Fujisawa, Tomoyuki, et al.
Publicado: (2014)

Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist’s point of view
por: Koo, So-My, et al.
Publicado: (2017)

Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease
por: Song, Ju Sun, et al.
Publicado: (2015)

Anti Jo-1 myositis. 'Mechanic's hands' and interstitial lung disease.
por: Taggart, A. J., et al.
Publicado: (2002)

Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis
por: Vojinovic, Tamara, et al.
Publicado: (2020)

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease
por: Lee, Hyun, et al.
Publicado: (2022)

Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study
por: Rivière, Amélie, et al.
Publicado: (2022)

A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
por: Baah, Samantha, et al.
Publicado: (2021)

In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
por: Chinoy, Hector, et al.
Publicado: (2006)

Respiratory bronchiolitis-interstitial lung disease
por: Sieminska, Alicja, et al.
Publicado: (2014)

Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
por: Misra, Abhinav K., et al.
Publicado: (2021)

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease
por: Moll, Sofia A., et al.
Publicado: (2020)

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases
por: Moll, Sofia A., et al.
Publicado: (2022)

Assessment of Optimal Screening Tests for the Detection of an Inflammatory Myositis-associated Interstitial Lung Disease
por: Castillo, Sonia, et al.
Publicado: (2020)

Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
por: Ceribelli, Angela, et al.
Publicado: (2023)

Interstitial Lung Diseases: Respiratory Review of 2013
por: Kim, Yong Hyun, et al.
Publicado: (2013)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
por: Chen, Fang, et al.
Publicado: (2022)

Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis
por: Cotton, Thaisa, et al.
Publicado: (2022)

Patients with End-stage Interstitial Lung Disease may have More Problems with Dyspnea than End-stage Lung Cancer Patients
por: Matsunuma, Ryo, et al.
Publicado: (2016)

Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
por: Kaieda, Shinjiro, et al.
Publicado: (2020)

Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases
por: Nurmi, Hanna M., et al.
Publicado: (2023)

Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease
por: Kase, Kazumasa, et al.
Publicado: (2021)

Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease
por: Wang, Yukai, et al.
Publicado: (2020)

Antibiotic prescription: An oral physician's point of view
por: Patait, Mahendra, et al.
Publicado: (2015)

The 6-min walk test as a primary end-point in interstitial lung disease
por: Harari, Sergio, et al.
Publicado: (2022)

Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model
por: Cao, Heng, et al.
Publicado: (2020)

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
por: Kang, Eun Ha, et al.
Publicado: (2010)

The lung as a possible target for the immune reaction in myositis
por: Danoff, Sonye K, et al.
Publicado: (2011)

Phenotypic clusters and survival analyses in interstitial pneumonia with myositis-specific autoantibodies
por: Lia, Yihua, et al.
Publicado: (2021)

Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights
por: Faverio, Paola, et al.
Publicado: (2018)

Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights
por: Faverio, Paola, et al.
Publicado: (2019)

Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
por: Ceribelli, Angela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7pf7u5rmevfokn86uui41p0ov6